Literature DB >> 4817445

Upper respiratory tract in cystic fibrosis. Ear-nose-throat survey of 50 children.

B Taylor, J N Evans, G A Hope.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4817445      PMCID: PMC1648718          DOI: 10.1136/adc.49.2.133

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  7 in total

1.  Nasal polyposis in patients with cystic fibrosis.

Authors:  H SHWACHMAN; L L KULCZYCKI; H L MUELLER; C G FLAKE
Journal:  Pediatrics       Date:  1962-09       Impact factor: 7.124

2.  Hearing loss, speech-language, and cystic fibrosis.

Authors:  R A Forcucci; E W Stark
Journal:  Arch Otolaryngol       Date:  1972-10

3.  The hearing of patients with cystic fibrosis.

Authors:  L L Kulczycki; J S Butler; D McCord-Dickman; G R Herer
Journal:  Arch Otolaryngol       Date:  1970-07

4.  Cystic fibrosis and hearing. Integrity of the upper respiratory tract as related to hearing sensitivity.

Authors:  L L Kulczycki; G R Herer; J S Butler
Journal:  Clin Pediatr (Phila)       Date:  1970-07       Impact factor: 1.168

5.  Audiometric testing.

Authors:  J Jerger; J G Neely
Journal:  Arch Otolaryngol       Date:  1971-01

6.  Hearing of patients with cystic fibrosis.

Authors:  J Siegel; W Taylor; L Kulczycki
Journal:  Arch Otolaryngol       Date:  1970-11

7.  Identification and follow up of children with exudative otitis media.

Authors:  T J Watson
Journal:  Proc R Soc Med       Date:  1969-05
  7 in total
  3 in total

Review 1.  Upper respiratory disease, sinusitis, and polyposis.

Authors:  V V King
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Nasal polyposis, opaque paranasal sinuses and usually normal hearing: the otorhinolaryngological features of cystic fibrosis.

Authors:  T J David
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

3.  Ear disease is not a common complication in cystic fibrosis.

Authors:  M Cipolli; M Canciani; M Cavazzani; P Uras; P Zampieri; G Mastella
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.